Research ArticleArticle
Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease
Yasuhiro Shimojima, Dai Kishida, Ken-ichi Ueno, Satoru Ushiyama, Takanori Ichikawa and Yoshiki Sekijima
The Journal of Rheumatology February 2019, jrheum.181192; DOI: https://doi.org/10.3899/jrheum.181192
Yasuhiro Shimojima
From the Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; the Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan. This study was supported by a Health and Labor Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan. Y. Shimojima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; D. Kishida, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; K.I. Ueno, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; S. Ushiyama, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; T. Ichikawa, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; Y. Sekijima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine and Institute for Biomedical Sciences, Shinshu University. Address correspondence to Dr. Y. Shimojima, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail: yshimoji@shinshu-u.ac.jp. Accepted for publication January 28, 2019.
Dai Kishida
From the Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; the Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan. This study was supported by a Health and Labor Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan. Y. Shimojima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; D. Kishida, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; K.I. Ueno, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; S. Ushiyama, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; T. Ichikawa, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; Y. Sekijima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine and Institute for Biomedical Sciences, Shinshu University. Address correspondence to Dr. Y. Shimojima, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail: yshimoji@shinshu-u.ac.jp. Accepted for publication January 28, 2019.
Ken-ichi Ueno
From the Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; the Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan. This study was supported by a Health and Labor Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan. Y. Shimojima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; D. Kishida, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; K.I. Ueno, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; S. Ushiyama, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; T. Ichikawa, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; Y. Sekijima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine and Institute for Biomedical Sciences, Shinshu University. Address correspondence to Dr. Y. Shimojima, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail: yshimoji@shinshu-u.ac.jp. Accepted for publication January 28, 2019.
Satoru Ushiyama
From the Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; the Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan. This study was supported by a Health and Labor Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan. Y. Shimojima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; D. Kishida, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; K.I. Ueno, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; S. Ushiyama, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; T. Ichikawa, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; Y. Sekijima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine and Institute for Biomedical Sciences, Shinshu University. Address correspondence to Dr. Y. Shimojima, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail: yshimoji@shinshu-u.ac.jp. Accepted for publication January 28, 2019.
Takanori Ichikawa
From the Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; the Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan. This study was supported by a Health and Labor Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan. Y. Shimojima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; D. Kishida, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; K.I. Ueno, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; S. Ushiyama, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; T. Ichikawa, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; Y. Sekijima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine and Institute for Biomedical Sciences, Shinshu University. Address correspondence to Dr. Y. Shimojima, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail: yshimoji@shinshu-u.ac.jp. Accepted for publication January 28, 2019.
Yoshiki Sekijima
From the Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; the Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan. This study was supported by a Health and Labor Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan. Y. Shimojima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; D. Kishida, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; K.I. Ueno, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; S. Ushiyama, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; T. Ichikawa, MD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine; Y. Sekijima, MD, PhD, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine and Institute for Biomedical Sciences, Shinshu University. Address correspondence to Dr. Y. Shimojima, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail: yshimoji@shinshu-u.ac.jp. Accepted for publication January 28, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease
Yasuhiro Shimojima, Dai Kishida, Ken-ichi Ueno, Satoru Ushiyama, Takanori Ichikawa, Yoshiki Sekijima
The Journal of Rheumatology Feb 2019, jrheum.181192; DOI: 10.3899/jrheum.181192
Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease
Yasuhiro Shimojima, Dai Kishida, Ken-ichi Ueno, Satoru Ushiyama, Takanori Ichikawa, Yoshiki Sekijima
The Journal of Rheumatology Feb 2019, jrheum.181192; DOI: 10.3899/jrheum.181192